INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,080 | +64.6% | 20,722 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $656 | +16.9% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $561 | +2.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $548 | -99.9% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -18.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $591,000 | -6.8% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $634,000 | +17.0% | 10,361 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $542,000 | +40.4% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | -8.7% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $423,000 | +20.2% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $352,000 | +7.0% | 10,361 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $329,000 | +23.7% | 10,361 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $266,000 | 0.0% | 10,361 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $266,000 | +67.3% | 10,361 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $159,000 | -18.5% | 10,361 | +82.2% | 0.00% | 0.0% |
| Q4 2019 | $195,000 | +364.3% | 5,687 | 0.0% | 0.00% | – |
| Q3 2019 | $42,000 | -43.2% | 5,687 | 0.0% | 0.00% | – |
| Q2 2019 | $74,000 | +7.2% | 5,687 | 0.0% | 0.00% | – |
| Q1 2019 | $69,000 | +6.2% | 5,687 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | -47.2% | 5,687 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $123,000 | +179.5% | 5,687 | +127.8% | 0.00% | – |
| Q2 2018 | $44,000 | -17.0% | 2,497 | 0.0% | 0.00% | – |
| Q1 2018 | $53,000 | +47.2% | 2,497 | 0.0% | 0.00% | – |
| Q4 2017 | $36,000 | – | 2,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |